These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 18752004)

  • 1. Vascular targeted therapies in oncology.
    Siemann DW; Horsman MR
    Cell Tissue Res; 2009 Jan; 335(1):241-8. PubMed ID: 18752004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the tumor vascular compartment to improve conventional cancer therapy.
    Feron O
    Trends Pharmacol Sci; 2004 Oct; 25(10):536-42. PubMed ID: 15380938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor rim cells: From resistance to vascular targeting agents to complete tumor ablation.
    Seidi K; Jahanban-Esfahlan R; Zarghami N
    Tumour Biol; 2017 Mar; 39(3):1010428317691001. PubMed ID: 28351332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computer Simulations of the Tumor Vasculature: Applications to Interstitial Fluid Flow, Drug Delivery, and Oxygen Supply.
    Welter M; Rieger H
    Adv Exp Med Biol; 2016; 936():31-72. PubMed ID: 27739042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical determinants of vascular network remodeling during tumor growth.
    Welter M; Rieger H
    Eur Phys J E Soft Matter; 2010 Oct; 33(2):149-63. PubMed ID: 20607341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vessel abnormalization: another hallmark of cancer? Molecular mechanisms and therapeutic implications.
    De Bock K; Cauwenberghs S; Carmeliet P
    Curr Opin Genet Dev; 2011 Feb; 21(1):73-9. PubMed ID: 21106363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
    Gacche RN; Meshram RJ
    Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor angiogenesis: a potential target in cancer control by phytochemicals.
    Singh RP; Agarwal R
    Curr Cancer Drug Targets; 2003 Jun; 3(3):205-17. PubMed ID: 12769689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growing tumor vessels: more than one way to skin a cat - implications for angiogenesis targeted cancer therapies.
    Leite de Oliveira R; Hamm A; Mazzone M
    Mol Aspects Med; 2011 Apr; 32(2):71-87. PubMed ID: 21540050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential role of vascular targeted therapy to combat against tumor.
    Chen B; Jin H; Wu K
    Expert Opin Drug Deliv; 2009 Jul; 6(7):719-26. PubMed ID: 19538038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenesis inhibitors. Drug selectivity and target specificity.
    Kesisis G; Broxterman H; Giaccone G
    Curr Pharm Des; 2007; 13(27):2795-809. PubMed ID: 17897024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases.
    Carmeliet P; Jain RK
    Nat Rev Drug Discov; 2011 Jun; 10(6):417-27. PubMed ID: 21629292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor angiogenesis and vascular normalization: alternative therapeutic targets.
    Viallard C; Larrivée B
    Angiogenesis; 2017 Nov; 20(4):409-426. PubMed ID: 28660302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenesis and Metabolism: Entwined for Therapy Resistance.
    Jiménez-Valerio G; Casanovas O
    Trends Cancer; 2017 Jan; 3(1):10-18. PubMed ID: 28718423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the tumor stroma in cancer therapy.
    Anton K; Glod J
    Curr Pharm Biotechnol; 2009 Feb; 10(2):185-91. PubMed ID: 19199950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smart Nanotherapeutic Targeting of Tumor Vasculature.
    Li Z; Di C; Li S; Yang X; Nie G
    Acc Chem Res; 2019 Sep; 52(9):2703-2712. PubMed ID: 31433171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The critical role of vascular endothelial growth factor in tumor angiogenesis.
    Amini A; Masoumi Moghaddam S; Morris DL; Pourgholami MH
    Curr Cancer Drug Targets; 2012 Jan; 12(1):23-43. PubMed ID: 22111836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redox Potential and ROS-Mediated Nanomedicines for Improving Cancer Therapy.
    Glass SB; Gonzalez-Fajardo L; Beringhs AO; Lu X
    Antioxid Redox Signal; 2019 Feb; 30(5):747-761. PubMed ID: 28990403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the tumor vasculature: a strategy to improve radiation therapy.
    Siemann DW; Horsman MR
    Expert Rev Anticancer Ther; 2004 Apr; 4(2):321-7. PubMed ID: 15056061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenes and tumor angiogenesis: the question of vascular "supply" and vascular "demand".
    Rak J; Yu JL
    Semin Cancer Biol; 2004 Apr; 14(2):93-104. PubMed ID: 15018893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.